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Summary 
Naegleria fowleri is a protist pathogen that can cause lethal brain infection. Despite 
decades of research, the mortality rate related with primary amoebic meningoencephalitis owing 
to N. fowleri remains more than 90%. The amoebae pass through the nose to enter the central 
nervous system killing the host within days, making it one of the deadliest opportunistic 
parasites. Accordingly, we present an up to date review of the biology and pathogenesis of N. 
fowleri and discuss needs for future research against this fatal infection.      
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1. Introduction   
Naegleria fowleri is a protist pathogen that is extensively dispersed in the environment. 
N. fowleri is the only pathogenic species in this genus. Given the opportunity and access, N. 
fowleri can cause fatal primary amoebic meningoencephalitis (PAM). Worryingly, mortality 
rates concomitant with PAM remain substantially high, irrespective of modern improvements in 
antimicrobial chemotherapy or supportive medical care. Being a free-living amoeba, N. fowleri 
can switch phenotype depending on the environmental conditions (Fig. 1). Under favourable 
conditions, it exhibits a reproductively-active trophozoite stage. The trophozoite stage is 
considered as the infective stage. Under non-nutrient conditions; but presence of water, 
trophozoites switch to a transient flagellate stage allowing long distance movement, often in 
pursuit of nourishment. During this stage, N. fowleri does not reproduce or form cyst. When the 
environment is adverse or unfavourable, trophozoites switch into a metabolically inactive or 
dormant form known as the cyst form. Like the flagellate phase, the cysts are non-feeding, and 
non-reproductive. Only the trophozoites of N. fowleri can feed, reproduce, and/or become cysts. 
The parasites enter hosts through the nasal route, travelling via the olfactory neuroepithelia and 
thus gaining entry to the central nervous system with the production of PAM. The intention of 
this review is to present a comprehensive review of our current understanding of N. fowleri and 
to propose directions for future research. Much of our present knowledge in the biology aspects 
of this genus comes from other Naegleria species, mainly N. gruberi. It cannot be considered to 
be representative of pathogenic N. fowleri but covered here briefly to provide basic 
understanding of this genus.     
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2. Primary amoebic meningoencephalitis  
 Primary amoebic meningoencephalitis is a haemorrhagic-necrotizing 
meningoencephalitis, symptoms include: headache, stiff neck, fever (38.5°C–41°C), changed 
mental status, seizures, and coma, resulting in fatality in most cases. PAM is accompanied by 
strong inflammation, often made up of neutrophils, eosinophils, macrophages and lymphocytes. 
The incubation period from being exposed to the parasite until the development of the disease 
varies from one to 16 days (1). People contract the parasite through exposure to contaminated 
water. Following infection, N. fowleri infiltrate the cribiform plate and the nasal mucosa then 
pass along the olfactory neuroepithelial route to gain entry to the brain to produce 
meningoencephalitis with quick cerebral edema, leading to cerebellar herniation and death (1,2). 
The olfactory bulbs exhibit haemorrhage, and an inflammatory exudate, while leptomeninges are 
congested, diffusely hyperemic with limited infiltration (3). Focal demyelination in the white 
matter of the brain and spinal cord has been observed (4,5). N. fowleri are witnessed at the base 
of the brain, hypothalamus, and midbrain. Histology reveals an severe inflammatory reaction, 
that typically consists of neutrophils with widespread regions of lytic necrosis and manifestation 
of N. fowleri trophozoites (6). Microscopic examination reveals many amoebae in the 
subarachnoid and perivascular spaces (3,6) (Fig. 2).  
 The earliest infection of PAM was reported in 1965 in Australia (7). To date, few 
hundred cases of PAM have been reported worldwide. Incidentally, most cases have been 
described from the United States, Australia, and Europe. Trophozoites are the only form found in 
the lesions. N. fowleri overrun the olfactory bulbs following spread to the posterior areas of the 
brain. N. fowleri has been isolated from the cerebrospinal fluid (CSF) of infected patients (8). 
Initial symptoms include serious headache and fever (38.5 – 41°C), and then nausea, vomiting, 
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and signs of meningeal irritation. Notably, involvement of the olfactory lobes may lead to 
disturbances in the sense of smell or taste and may be prominent early in the progression of the 
disease, whilst visual instabilities may also ensue. The patient may experience confusion, 
irritability, and may behave irrationally prior to lapsing into seizures and coma (3). The disease 
is reffered to as “primary” to differentiate it from infection produced by other parasitic amoebae, 
which attack the CNS following dissemination through blood.  
2.1. Risk factors 
 Being free-living amoeba, N. fowleri is present in rivers, freshwater lakes, canals, spas, 
geothermal springs, untreated domestic water supplies and swimming pools. In the majority of 
cases, PAM occurs in young people who have recently been exposed to or had contact with 
contaminated water. Notably, PAM cases go unnoticed in developing countries, among millions 
of other infections. For example, in countries such as Pakistan, temperatures can reach up to 
50°C, whereas water temperatures are documented at 30 – 35°C, and so with persistent power 
cuts, millions of people go to freshwater canals, ponds, standing water etc. for “recreational 
activities” on a daily basis for months (Fig. 3). The occurrence of N. fowleri in these waters, 
coupled with the absence of awareness and/or control measures, along with a poor healthcare 
infrastructure, and unavailability of effective drugs to counter this disease is a major health risk 
for these communities. PAM has also been linked with ablution practice amongst religious 
groups. In particular, Muslims pray five times a day. Ablution is performed before every prayer, 
for cleansing. Performing ablution encompasses washing the hands, mouth, face, nose, ears ,arms 
and feet. However, when cleaning their nose, many individuals drive water forcefully up their 
nostrils, despite this not being a mandatory as a part of ablution. Even though ablution practices 
have remarkable health benefits, the process can only fulfil its purpose if the water supplies are 
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free of pathogenic microbes and are uncontaminated(Fig. 4) (9). Thus there is an urgent need for 
increased awareness so that procedures to make water safer for ritual nasal rinsing are in place. 
Utilizing boiled or filtered water, or indeed water that has been sanitized using the endorsed 
concentrations of chlorine coupled with more careful ablution (not forcing water inside the 
nostrils fervently) will minimize the risk in contracting this devastating disease. Additionally, in 
many developing countries, water scarcity is a major problem and public has to store water in 
tanks for days to weeks for their routine consumption which presents a major risk factor. The 
general public needs to be made aware of the risks related with the use of storage tanks at home 
and at prayer places. As a vast majority of public often carry out ablution at mosques in 
preparation of their prayers, it is absolutely vital that the water storage tanks are cleaned and 
disinfected routinely in mosques (9). Additional religious festivals such as the Kumbh Mela, 
where millions of Hindus meet in the Indian city of Allahabad for a ceremonial bath in the sacred 
Ganges River present a threat to public health in the transmission of infectious agents. In 
addition, nasal cleansing using neti pots is often used to provide relief to patients with sinusitis. 
Ayurvedic practices also include nasal irrigation, known as “jala neti,”. This comprises of 
inhaling water using cupped hands and consquently blowing it out, via an Aladdin’s lamp-shaped 
device (9). Though nasal irrigation stimulates good sinus and nasal health, it can only be 
effective if disinfected, filtered, or boiled water is utilized. Given the widespread use of this 
practice globally, a large number of PAM cases is likely missed out. Thus there is a need for 
increased awareness among physicians as well as the community.  
3. Clinical and laboratory diagnosis 
Patients exhibiting CNS symptoms together with a history of swimming or use/exposure 
to contaminated water for nasal cleansing should be suspected of PAM. The computed 
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tomographic scan (CT) reveal involvement of the CNS, as cisternae, around and above the 
midbrain and the subarachnoid spaces are eliminated on pre-contrast CT. Noticeable 
augmentation is seen after intravenous contrast medium administration. Whereas the ventricular 
size is usual, the sulci and adjacent gray matter are also intensely enhanced, (10). The definitive 
diagnosis of PAM involves CSF findings, i.e., presence of amoebae in the CSF. In the majority 
of cases, motile trophozoites are observed in CSF by wet mount. Brief centrifugation of the CSF 
at 5,000 x g for 5 min is helpful to concentrate amoebae. In addition to microscopy, 
immunofluorescence assay (IF) (11-13), enzyme-linked immunosorbent assay (ELISA) (14), 
flow cytometry (15), and PCR-based assays have been developed. Assays should be employed 
on both CSF and nasal exudates. Apart from the presence of amoebae, CSF findings in PAM are 
comparable to bacterial meningitis. For example, the red blood cell count in CSF increases 
several fold from 250 cells per mm3 in the early stage to 25,000 cells per mm3 in the late stage. 
Similarly, the white blood cell count is raised, with a polymorphonuclear leukocyte 
predominance, with a range of 300 cells per mm3 to as high as 26,000 cells per mm3. The CSF 
pressure is typically raised (300 – 600 mm H2O). The protein concentration can range from 100 
mg per 100 mL to 1000 mg per 100 mL, while glucose might be 10 mg per 100 mL or less (16). 
Endeavours ought to be made to culture the amoebae from the CSF. A few drops of CSF should 
be transferred to a non-nutrient agar plate seeded with bacteria and amoebae growth should 
observed daily for up to seven days. Amoebae appear as the trophozoite form within 1 – 2 days. 
N. fowleri can be differentiated from other pathogenic amoebae using enflagellation experiment 
by mixing one drop of amoebae culture or sedimented CSF and one mL of distilled water for 1 – 
2 h with periodic observation for the presence of flagellates, however the molecular methods 
remain the method of choice (17). An indirect immunofluorescence assay (IIF) for the 
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recognition of N. fowleri antigen in paraffin-embedded brain tissue slide is routinely performed 
at Centers for Disease Control. Additionally, PCR-based assays have been established for the 
sensitive, rapid, and precise identification of N. fowleri in clinical samples, and cultured amoebae 
from patients and the environment (14, 18-35) (Table 1).  
Overall, patients exhibiting symptoms involving the CNS and similar to bacterial 
meningitis, but having negative CSF Gram stain and a recent history of swimming and/or contact 
with nasal freshwater, should be suspected of PAM. If active amoebae are not observed, the 
nasal exudates and CSF should be subjected to amoeba identification using ELISA, IF, and PCR 
assays for confirmation.   
4. Chemotherapeutic strategies 
The fatality rate associated with PAM is more than 90%. There only are 5 documented 
survivors of PAM, who received combination drugs. All treatments included amphotericin B, 
which affects membrane integrity (Table 2) (11, 36-40). At present, the U.S. Centers for Disease 
Control and Prevention (CDC) recommends that patients suspected of PAM should be given the 
following combination of drugs: deoxycholate amphotericin B intravenously (IV) and 
intrathecally (IT), an azole drug such as fluconazole IV or orally (PO), azithromycin IV or PO, 
rifampin IV or PO, miltefosine PO, and dexamethasone IV (Table 2). While N. fowleri is 
sensitive to amphotericin B, the minimum inhibitory concentration (MIC) of amphotericin B 
against N. fowleri is variable, among different isolates and may range from 0.026 – 0.078 mg per 
mL (41-43). However, clinical use of amphotericin B is limited due to its toxicity, including 
acute infusion-related reactions and dose-related nephrotoxicity. New formulations of 
amphotericin B have been introduced with improved toxicity profiles. For example, the MIC for 
deoxycholate amphotericin B was 0.1 µg/mL, while that of liposomal amphotericin was 10 times 
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higher at 1 µg/mL suggesting that deoxycholate amphotericin B should be preffered over 
liposomal or lipid complex formulation.  
Among other drugs of the azole class, ketoconazole showed the lowest MIC (out of 
ketoconazole, fluconazole, and itraconazole tested). Voriconazole exhibits inhibitory and 
amoebacidal effects. Both miconazole and fluconazole have been used as part of successful 
treatment regimens, although none of the drugs tested are as active as amphotericin B (36, 37, 
39-46). Recently, it is shown that amphotericin B and azithromycin exhibit synergistic effects, 
indicating that the combined use of these two drugs may result in successful prognosis (39, 46, 
47).  
Miltefosine is an anticancer agent, that showed potent activity against N. fowleri in vitro 
and in vivo effects (46, 48, 49). Notably, miltefosine can cross the blood-brain barrier and 
concentrate in brain tissue, thus making this a useful drug against PAM. Recently, the CDC has 
recommended its use in the USA under single-patient emergency Investigational New Drug 
(IND) protocols. It was first given to a PAM patient in 2010 in combination with amphotericin 
B, azithromycin, fluconazole, and rifampin; however, the drug was not administered to the 
patient until 5 days after patient’s initial presentation to  hospital and the patient did not survive 
(40). In 2013, the U.S. CDC has been able to procure a supply of miltefosine under an expanded 
access IND allowing for rapid deployment to PAM patients in the U.S. In 2013, two U.S. PAM 
patients received miltefosine, together with amphotericin B, azithromycin, fluconazole, and 
rifampin, shortly after their hospital admissions, which resulted in successful treatment of PAM 
(39, 40).   
Other candidate drugs that have shown anti-N. fowleri effects but not tested clinically, 
include antipsychotic drugs, i.e., trifluoperazine and chlorpromazine (49-51), acrolein, a 
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metabolic product of cyclophosphamide (52), artemisinin (53, 54), cannabinoids (55), mono- and 
di-amidino derivatives (56), synthetic antimicrobial peptide, tritrypticin (57), and corifungin, a 
water-soluble polyene macrolide (58). Of note, corifungin resulted in 100% survival of mice for 
17 days post-infection.  
In addition to antimicrobial chemotherapy, there is a need to manange PAM patients 
effectively. The overwhelming inflammation of the brain leading to cerebral edema, along with 
raised eminent intracranial pressure and consequent herniation of the brain often leads to the 
death of PAM patients. Among five documented survivors, four patients received 
dexamethasone to reduce the intracranial pressure. The management of one of the PAM patients’ 
included drainage of CSF via an external ventricular drain, hyperosmolar therapy with mannitol 
and 3% saline, moderate hyperventilation (goal PaCO2: 30 – 35 mm Hg), and induced 
hypothermia (32 – 34°C; Linam et al. 2015). Largely, these findings indicate that in addition to 
antimicrobial chemotherapy, PAM patients should have their intracranial pressure closely 
monitored.  
5. Pathogenesis  
In vivo, ex vivo and in vitro models have been developed to study molecular mechanisms 
associated with N. fowleri pathogenesis. In vivo, mice are inoculated intranasally with N. fowleri 
that results in high mortality rate. The susceptibility of mice is influenced by weight (mice 
weighing less than 15 g are more sensitive), and age (younger mice are more sensitive) (59, 60). 
Following infection, N. fowleri are observed in mucous layer of the olfactory epithelium within 8 
h post-infection (61) and infected mice exhibit focal inflammation with the presence of N. 
fowleri in the submucosal nerve plexus, olfactory nerves penetrating the cribriform plate, and the 
olfactory bulb of the brain within 24 h post-infection. Following 96 h, the inflammatory 
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response, primarily in the form of neutrophil polymorphs, is severe in the olfactory bulb and the 
brain, with tissue damage (62-65). Numerous amoebae are seen interspersed with the 
degenerating neurones, glial processes, and neutrophil polymorphs with major concentrations in 
the perivascular regions and in the lumina of blood vessels (66). When N. fowleri are incubated 
with host cells in vitro, host cells show cell shrinkage, cell damage, invasion and destruction via 
phagocytic processes (63). Using ex vivo model, Gianinazzi et al., (67) showed that infection of 
organotypic slice cultures from rat brain with amoebae is comparable to findings with in vivo 
infection, suggesting its usefulness in the study of N. fowleri pathogenesis. For simplicity, the 
pathogenicity of N. fowleri is divided into contact-mediated and contact-independent 
mechanisms (Fig. 5).   
5.1. Contact-dependent mechansims  
Adhesion is a primary step in N. fowleri-mediated host cell damage. The capability of N. 
fowleri to bind to nasal mucosa, locomotion, and chemotactic response to nerve cell components 
play a substantial role in disease progression (68-70). Binding is mediated by adhesins expressed 
on the surface of N. fowleri. Two integrin-like proteins, co-localized to the focal adhesion-like 
structures, have been described in N. fowleri. In support, anti-integrin antibody reduced binding 
of N. fowleri to extracellular matrix (ECM) (71). A fibronectin binding protein of 60 kDa is 
described, which is important for N. fowleri-mediated host cells cytotoxicity. Protein kinase C 
activity is shown in N. fowleri extracts that affects binding to and cytotoxicity of host cells (70). 
N. fowleri is shown to induce reactive oxygen species (ROS) in host cells, resulting in host cell 
damage (72). Following binding, phagocytosis and amoebastomes are involved in N. fowleri-
mediated host cell damage via piecemeal consumption of target cells mediated by a sucker 
apparatus protruding from the surface of N. fowleri (73-75). These processes are actin-dependent 
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and involve polymerization of monomeric G-actin into filamentous F-actin. A nfa1 gene of 360 
bp has been identified that encodes Nfa1 protein (13.1 kDa), expressed on the pseudopodia (76). 
Anti-Nfa1 antibody or gene silencing of nfa1 reduces N. fowleri-induced host cell cytotoxicity 
(77-82). Overall, the expression of Nfa1 appears to be important for N. fowleri pathogenesis. In 
addition, surface membrane-enriched fractions of N. fowleri contain potent cytolytic activity 
unaffected by treatment at high temperature (83). Later studies identified a 17 kDa membrane 
protein, Mp2CL5, expressed in N. fowleri but not in non-pathogenic species, suggesting that it 
may play a role in the pathogenicity of N. fowleri (84, 85).    
5.2. Contact-independent mechanisms   
A 66 kDa membrane-bound cytolytic pore-forming protein, N-PFP is expressed by N. 
fowleri (86). It depolarizes the membrane potential, affecting membrane integrity (86). Two 
pore-forming polypeptides, Naegleriapores A and B, have been identified from N. fowleri. Both 
polypeptides have comparable structural properties with antimicrobial and cytolytic polypeptides 
of amoebapores of E. histolytica and of cytotoxic natural killer and T cells (87-89).  
Phospholipase A, phospholipase A2, phospholipase C, sphingomyelinase, 
neuroaminidase, elastase, and proteolytic enzyme activities are observed in cell-free lysate (90,-
92). In PAM patients, extensive demyelinization is observed in the white matter, which is likely 
the result of phospholipases (4). Amoebae degrade sphingomyeline with liberation of choline, 
sphingosine and fatty acids. It is further confirmed that N. fowleri releases phospholipases, 
lysophospholipase and sphingomyelinase, as well as factors that cause damage to the lipid-rich 
cytoplasmic membrane of cells and demyelinizes nerve tissue (92, 93).  
N. fowleri exhibit extracellular proteolytic activity (92, 94) that degrade zonula 
occludens-1 (ZO-1) and claudin-1 proteins but not occludin (95). The optimal protease activity is 
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observed at pH 7.0 and 35°C and activity can be inhibited mainly using cysteine proteases 
inhibitors, while serine protease activity is also observed (94). Additionally, acid proteinase, N-
acetylglucosaminidase, acid phosphatase, 5’-nucleotidase, aspartate aminotransferase, alpha-D-
glucosidase, and aminopeptidase activities have been shown (83). Among these, acid proteinase, 
N-acetylglucosaminidase, and acid phosphatase are connected with cytoplasmic granules that are 
similar to lysosomes; 5’-nucleotidase is associated with surface membrane; aspartate 
aminotransferase is related with mitochondria; and alpha-D-glucosidase and an aminopeptidase 
is connected with surface membrane as well as lysosomal particles (83). In addition, cysteine 
proteases, lipases, sphingomyelinase, elastase, cathepsin B-like proteases, beta-glucosidase, beta-
galactosidase, beta-fucosidase, alpha-mannosidase, hexosaminidase, arylsulfatase A, and beta-
glucuronidase, sphingomyelinase, neuraminidase, or arylsulfatase B, phospholipases, 
lysophospholipases, sphingomyelinases, neuraminidase, electrondense granules (small 
cytoplasmic components endowed with proteolytic activities), peroxiredoxin, thrombin receptor 
have been described, which may play a role in N. fowleri pathogenesis (92, 96-100). A 30 kDa 
cysteine protease has been described in N. fowleri that degrades ECM and produces host cell 
toxicity. In addition, cysteine proteases of approx.. molecular weights of 58 kDa, 128 kDa, and 
170 kDa are detected in N. fowleri (101, 102). Two cathepsin B and cathepsin B-like cysteine 
protease genes, cathepsin B (nfcpb) and cathepsin B-like (nfcpb-L) with 38.4 and 34 kDa 
molecular weight have been described that degrade IgA, IgG, IgM, collagen, fibronectin, 
hemoglobin, and albumin (103).  
N. fowleri produce nitric oxide in vitro, that share epitopes with the mammalian nitric 
oxide synthase, suggesting that nitric oxide may participate in N. fowleri pathogenesis (104). N. 
fowleri exhibit hemolytic activity. The hemolytic activity is membrane-associated, and 
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unaffected by a high salt concentration, chelating agents, and pH extremes (83). More recently, a 
heat shock protein 70 (HSP70) has been identified. The Nf-cHSP70 is contained in the 
cytoplasm, pseudopodia, and phagocytic food-cups. The inhibition of synthesis of Nf-cHSP70 
inhibits N. fowleri proliferation as well as reducing host cell cytotoxicity. These results suggest 
that Nf-cHSP70 may play an significant role in stimulating the proliferation and in the regulation 
of the host’s immune system (85, 105). Among other potential pathogenicity factors include, (i) 
cyclophilin that is overexpressed in highly pathogenic N. fowleri, (ii) apoptosis-linked gene-2-
interacting protein X1 (AIP1), a regulator of endosomal sorting of cellular material between 
organelles (85). Golgi-localized transmembrane protein HID-1 is involved in vesicular 
exocytosis by preventing the mis-sorting of peptides to lysosomes for degradation (106, 107). 
Both AIP1 and HID-1 are thought to be useful as N. fowleri pathogenicity factors, potentially 
acting to regulate vesicular trafficking in the amoeba (85). Other factors include, (iii) Ras-related 
protein Rab-1, which may be involved in vesicular trafficking and, thus, in the phagocytosis of 
target cells, (iv) myosin II heavy chain as well as myosin Ie (likely involved in phagocytic 
processes), (v) Villin-1 protein, likely involved in actin-dependent pathogenic processes may 
also be important for N. fowleri pathogenesis (85). 
6. The host-damage response to N. fowleri 
The fact that immunization of mice with N. gruberi affords protection against subsequent 
challenge with N. fowleri, suggests the role of immune response in PAM. Protection can also be 
transferred in mice by immune serum (3). At early satges of infection, the host secretes mucus 
that traps amoebae. The exposure to N. fowleri induces activation of innate defence, such as 
mucin secretion (MUC5AC) and inflammation (IL-8 and IL-1 beta) in respiratory epithelial 
cells, via ROS production (108). Mucins inhibit binding of N. fowleri to cells and inhibit 
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cytotoxicity in vitro and in vivo. However, few N. fowleri penetrate the epithelium and induce an 
inflammatory reaction (62, 109). Eosinophils and neutrophils surrounding N. fowleri are 
observed during later stages of infection. The inflammation increases with time, with a major 
neutrophil response. To determine whether inflammation plays a role in tissue damage, CD38-/- 
knockout mice with deficiencies in chemotaxis were compared with the parent strain, C57BL/6J 
were used. It was shown that inflammation and mortality are delayed in knockout mice, 
suggesting that the host inflammatory response and polymorphonuclear cell lysis contribute to 
the CNS tissue damage (109). In vitro, microglial cells exposed to N. fowleri lysates induce pro-
inflammatory cytokine release, including TNF-α, IL-6, and IL-1β (110). Likewise, astrocytes 
exposed to amoebae lysates lead to expression of IL-8, IL-1 beta, and IL-6 in a ERK, JNK and 
p38 MAPKs-dependent manner (111, 112).  
In vitro studies show that neutrophils do not kill N. fowleri in vitro, unless pre-exposed to 
conditioned medium (CM) from Phytohaemagglutinin (PHA)-stimulated mononuclear 
leukocytes. Additionally, the presence of antibody or complement augment N. fowleri killing by 
CM modified neutrophils. Similarly, neutrophils from N. fowleri-immunized mice are adept of 
killing N. fowleri. Neutrophils surround N. fowleri prior to killing, through contact-dependent 
and contact-independent mechanisms described above. A single neutrophil is unable to 
phagocytose an entire N. fowleri, several neutrophils are able to rupture N. fowleri by pinching 
off and engulfing portions of it (3, 113, 114). TNF-α stimulates the adherence of neutrophils to 
N. fowleri, followed by destruction of N. fowleri. Notably, TNF-α augment the neutrophil 
activity by enhancing oxygen radical production. Neutrophils which lack myeloperoxidase but 
have a normal oxygen-dependent respiratory burst do not possess amoebicidal properties. 
Arginine, a scavenger of hypochlorite, reduces ability of neutrophils to kill N. fowleri. Catalase 
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inhibits cidal activity of neutrophils, suggesting that TNF-α-mediates destruction of amoebae by 
neutrophils (115-117). Treatment of immunized mice with monoclonal antibody NIMP-R10, that 
causes selective neutrophil depletion led to increased mortality when challenged with N. fowleri. 
In contrast, immunized mice without antibody treatment show more than 95% survival, together 
with significant neutrophil response in nasal mucosa and olfactory lobes (118).  
Activated macrophages exhibit N. fowleri killing by producing nitric oxide in an 
arginine-dependent cytolytic mechanism and non-oxidative mediators including TNF-α and IL-1 
and possibly other factors. Notably, TNF-α alone, or in combination with IL-1 is neither 
amoebicidal nor amoebistatic (119, 120). Amoebicidal activity of the CM from activated 
macrophages can be recovered by ammonium sulfate precipitation, while heat treatment 
inactivates, suggesting their proteinaceous nature (121). Similarly, amoebicidal activity of 
natural killer cells increases during the course of infection, likely due to other anti-ameobic 
factors that enhance amoebae killing. 
Given that antibodies augment host cell-mediated amoebae killing, several surveys were 
conducted to detect normal exposure to amoebae. N. fowleri antibody is detected in normal 
human sera and saliva with titres ranging from 1:5 to 1:20. The antibodies belong to IgA, IgG, 
and IgM (3, 122-125). In vitro studies show that sIgA are capable of inhibiting N. fowleri 
binding to collagen type I (126), as well as blocking proliferation of N. fowleri, cytotoxicity of 
amoebae against host cells in vitro and in vivo, suggesting that antibodies weaken the virulence 
of N. fowleri (127, 128). 
Fresh adult human serum exhibit amoebicidal effects, while N. fowleri proliferation is 
inhibited by incubation in culture medium complemented with 10% fresh human serum. Heat 
inactivation (56°C, 30 min) of serum abolished lytic and inhibitory effects, and suggested the 
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role of complement via the alternative pathway. The presence of anti-N. fowleri antibody 
enhance amoebicidal effects (129-131).   
6.1. Immune evasion 
The nasal mucosa is the first line of defence. To overcome this barrier, N. fowleri is 
shown to possess mucinolytic activity. A 37 kDa protein with mucinolytic activity has been 
identified in N. fowleri that can be inhibited by cysteine protease inhibitors, suggesting that 
amoebae evade mucus by degrading mucins via proteases (109). Post-infection, there is an 
impairment of the blastogenic response of splenocytes to N. fowleri (132). Lymphoblastic 
transformation induced by T-cell mitogen is reduced in comparison to the uninfected control 
mice. The blastogenic response to B-cell mitogen remains depressed in the infected mice up to 
14 days post-infection, suggesting that there is a suppression of cell-mediated immunity during 
infection (133). Although, weakly pathogenic and non-pathogenic amoebae are lysed by 
complement, but virulent N. fowleri are resistant to complement-mediated lysis (134). The 
chelation of extracellular calcium enhanced complement-mediated N. fowleri lysis, suggesting 
that Ca2+ ions impact complement resistance in N. fowleri (135). N. fowleri resist complement 
damage via expression of complement-regulatory proteins, and shedding of membrane attack 
complex (C5b-C9) on vesicles (136, 137). Neither a repair process involving de novo protein 
synthesis nor a complement-inactivating protease is involved in increased resistance of amoebae 
to complement-mediated lysis (138), except the likely expression of complement-regulatory 
proteins. To this end, N. fowleri express a “CD59-like” surface protein (18 kDa) that may play a 
role in complement resistance and possibly protect amoebae against action of pore-forming 
proteins (139, 140). When exposed to normal human serum, membrane blebbing is observed on 
the surface of complement-resistant N. fowleri that likely represents shedding of the attack 
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complex. This is further supported by treatment of complement-resistant N. fowleri with 
cytochalasin D or cytochalasin B, which increased amoebae susceptibility to complement 
damage (137). Enzymatic removal of surface components from N. fowleri with 
phosphatidylinositol-specific phospholipase C or with endoglycosidase H increased the 
susceptibility of amoebae to complement-mediated lysis (136). Following exposure to serum, 
activation of protein kinases is observed including serine/threonine or tyrosine kinases, involved 
in complement resistance (141). Blocking activation of protein kinases makes N. fowleri 
susceptible to complement lysis.  
The ability of N. fowleri to internalize surface-bound antibody enable them to evade the 
host’s immune defences (3). Although sIgA antibodies are capable of inhibiting N. fowleri 
binding, amoebae are capable of eradicating antigen-antibody complex on the surface through 
capping and internalizing surface-bound antibody (126, 142).  
6.2. Immunization  
Intravenous, intranasal, subcutaneous, and intraperitoneal immunization of mice with 
formalin/formaldehyde-fixed N. gruberi affords protection against subsequent intranasal 
challenge with N. fowleri, albeit intravenous inoculation provides greater protection (3). Mice 
immunized with intact N. fowleri show better survival rate on challenge than those immunized 
with cell fragments, and N. gruberi is a better immunogen than N. fowleri (143-146). Cry1Ac 
protoxin protein, produced by the bacterium Bacillus thuringiensis, is a useful mucosal adjuvant 
(62). For example, N. fowleri lysates co-administered with Cry1Ac induces 100% protection 
against subsequent challenge with N. fowleri (62). The protection is mediated through increased 
metaplasia in the olfactory epithelium, allowing for secretion of IgA (147), as well as increased 
activated lymphocytes, and augmenting Th-1 and Th-2 type immune response in STAT6-
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dependent manner (148). Cholera toxin is also shown to be useful adjuvant. Immunization with 
N. fowleri lysates plus Cholera toxin offers 100% protection (survival up to 100%) against 
subsequent challenge with N. fowleri (149). Immunization with amoebae culture supernatant 
produced a survival rate of 67 - 78%. Fractionation showed that high molecular weight fraction 
(>200 kDa) provided greater protection. Again, the degree of protection is related to levels of 
anti-Naegleria antibodies. Histological findings show that this protection is expressed at the 
nasal mucosa, and possibly results from the combined effects of polymorphonuclear leukocyte-
mediated killing of N. fowleri and mechanical elimination of amoebae by extensive shedding of 
necrotic epithelium (118, 150).  
As the majority of cases prove fatal, intracisternal passive immune therapy in rabbits with 
PAM has been tested. The results showed that passive intracisternal treatment using anti-N. 
fowleri immune serum or its immunoglobulin G fraction, or the monoclonal antibody provides 
consistent, albeit temporary protective effects. The protective effect is heat-resistant to 56°C, 
suggesting that passive intracisternal antibody treatment may assist as an adjunctive therapy in 
PAM (159). More recently, rNfa1 has been tested as a potential vaccine candidate. Mice 
immunized intra-peritoneally or intra-nasally with rNfa1 protein develop specific IgG, IgA and 
IgE antibodies. High levels of the Th1 cytokine, IF-γ, and the regulatory cytokine, IL-10, are also 
induced, associated with prolonged survival time of mice (110). Later studies tested nfa1 DNA 
vaccination in mice. Mice vaccinated intranasally with viral particles of nfa1 exhibit high levels 
of IgG together with higher IL-4 and IF-γ production compared with the control groups, 
suggesting a Th1/Th2 mixed-type immune response, associated with significantly higher survival 
rates of up to 90%. These findings showed that nfa1 vaccination can provide protective 
immunity (111, 112). 
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7. Cell Biology and Species determination  
N. fowleri was discovered by Fowler and Carter in Australia (7) as the causative agent of 
PAM, and named in honour of Dr Malcom Fowler who first recognized the disease. Among the 
genus Naegleria, this is the only pathogenic species to be isolated from PAM patients. It has 
three stages in its life cycle, an amoeboid stage, a flagellate stage, and a cyst stage. The flagellate 
stage is transient, that is non-feeding, non-reproductive, and non-encysting stage. Upon 
favourable conditions, cyst stage excysts into amoeboid stage. The three forms and their inter-
conversion make this protist an excellent model to study cellular differentiation processes.  
 The amoeboid stage is characterized by a large nucleus with nucleolus, numerous 
mitochondria, food vacuoles, a contractile vacuole, endoplasmic reticulum enclosed within a 
plasma membrane, ribosomes, membrane-bound cytoplasmic organelles (152-154). The 
amoeboid stage is long and slender (8-15 µm) and move by forming one or more lobose 
pseudopodia (153-155). Cysts are spherical, with a smooth single layer, often clumped closely 
together, and 7-12 µm in diameter. Ultrastructure examination reveals an average of one to two 
mucoid-plugged pores per cyst, through which trophozoite emerges (3). The flagellate has an 
elongate, pear-shaped body, usually possessing two flagella of equal length, a nucleus in the 
narrower anterior region, and no cytostome. There is a distinct nuclear membrane and nucleolus, 
vacuoles and cytoplasmic inclusions, mitochondria, and rough endoplasmic reticulum. The 
kinetic apparatus consists of flagella and their associated kinetosomes, rhizoplast, and thin-
walled fibrils. Neither centrioles nor kinetosomes are found in amoeboid stage, suggesting its 
synthesis de novo during transformation of into the flagellate form (152-154, 156). The 
rhizoplast is proteinaceous with subunit molecular weight of approximately 240 kDa (157). The 
flagellates express tubulin that is similar to other tubulins in molecular weight (55 kDa), amino 
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acid composition, electrophoretic mobility, and nucleotide composition (158, 159 ). There are 2 
types of microfilament in the cytoplasm of N. fowleri (160). Thin, actin-like microfilaments, 5-7 
nm in diameter in the non-motile amoebae. In actively motile amoebae, these microfilaments 
combine to form collateral bundles in close proximity to the plasma membrane. Thick, myosin-
like microfilaments, 17-19 nm in diameter also occur in the amoebae cytoplasm (160). The 
purified actin share attributes with other actins, including molecular weight, strong binding to 
DEAE-cellulose, binding to DNase I, reversible polymerization to F-actin, binding of rabbit 
myosin subfragment 1 to give distinctive arrowheads, and activation of myosin Mg2+-ATPase 
(161, 162).  
N. fowleri is shown to exhibit locomotion at 37°C (163). On an agar plate with E. coli, 
amoeba exhibits growth and movement at the rate of 1 to 3 mm per day at 23°C, 7 to 14 mm per 
day at 37°C, and 7 to 14 mm per day at 43°C (164), making it a useful model to study 
locomotion. The amoeba locomotion involves cytoplasmic streaming, pseudopod production, 
cell polarity and focal contact production that requires actin-based cytoskeleton in a chemotactic 
and chemokinetic-dependent manner towards live cells and extracts of bacterial species. N. 
fowleri responds to bacteria through chemokinesis, chemotaxis, and formation of food cups 
(165). For locomotion on a glass substrate, two types of contact are made: one, formed at a 
considerable distance from the substrate in deionized water, termed as “associated contact”, from 
which filopodia are produced, which form close contacts, termed as “focal contacts” (166). The 
associated contact is transient, in contrast to the focal contacts, which are stable. Focal contact 
sites are left behind on the glass surface (“footprints”) when the amoeba moves away. The 
locomotion is affected by the ionic strength of the medium and particularly the valency of the 
cation component (166). Similar to glass substrate, amoeba carries out locomotion at the water-
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air interface, suggesting that the surface tension alone may deliver suitable properties for the 
adhesion and translocation of amoebae. The transitory swimming flagellate stage of Naegleria is 
capable of docking at the interface, making stable adhesions to it, and then reverting to the 
amoeboid phenotype. On the contrary, amoebae resident at the water-air interface can convert to 
swimming flagellates and escape into the bulk liquid phase (167).  
 The average cell dry mass is constant during log growth at 150 pg per amoeba, but 
decrease 30%, during stationary phase. During log growth, 80-85% of the cell dry mass is 
protein (120 pg per ameba). During log and stationary growth phases, carbohydrate content is 
approximately 15 pg per amoeba, and RNA is about 18 pg per amoeba. Total DNA content is 0.2 
– 0.3 pg per amoeba during log growth, but it increases during transition from log phase to 
stationary phase and then gradually decreases to nearly initial levels. The peak in DNA content 
corresponds to an increase in the average number of nuclei per amoeba, following which the 
nuclear number decreases as the cells enter stationary growth phase. The RNA content is 
approximately 18 pg per amoeba (3, 168, 169). The trophozoites expresses high levels of surface 
glycoconjugates that contain alpha-D-mannose, alpha-D-glucose, and terminal alpha-L-fucose 
residues (170, 171). N. fowleri is shown to possess the thiol compound trypanothione, which was 
hitherto thought to occur in Kinetoplastida only. The trypanothione/trypanothione reductase 
system may also be useful “drug target” without targeting the human host (51). Similarly, 
Selenium (Se) is found in selenoproteins as the 21st amino acid (selenocysteine, Sec, or U), 
involved in growth, proliferation, cellular redox balance, and has been identified in Naegleria. 
Additionally, beta-glucosidase, beta-galactosidase (172), acid phosphatase and heme proteins 
(173), catalase, phospholipase A, and sphingomyelinase activity (3), pyrophosphate-dependent 
phosphofructokinase (PPi-PFK) (174), cytosolic heat shock protein 70 (Nf-cHSP70) (175), low-
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molecular-mass thiol compounds (176), tet-like dioxygenase (177), sterol biosynthesis (178), 
malic enzyme, 3-hydroxybutyrate dehydrogenase, isocitrate dehydrogenase, 6-phosphogluconate 
dehydrogenase, L-threonine dehydrogenase, glyceraldehyde-3- phosphate dehydrogenase, 
superoxide dismutase, hexokinase, phosphoglucomutase, uridine diphosphate-glucose 
pyrophosphorylase, 3-N-acetylglucosaminidase, aldolase, and glucose phosphate isomerase, 
proteases, lipases, phosphatases, esterases, calmodulins have been identified (179, 180).  
7.1. Genome of the genus Naegleria  
The nuclear DNA content of Naegleria is approximately 0.2 – 0.3 pg per amoeba, 
whereas Acanthamoeba has 1 – 2 pg / amoeba, while Amoeba proteus is about 34 – 43 pg / 
amoeba (181, 182). DNA content is relatively constant during log to post-log phase transition 
(169). N. fowleri genome is diploid (66 MB), while the haploid genome size is 29.62 MB with 
GC content of 35.4% and 17,252 open reading frames (85, 183, 184). Of interest, the haploid 
genome size of N. gruberi is 40.96 MB with GC content of 33.1%, and composed of at least 12 
chromosomes with sizes ranging from 0.7 to 6.5 MB. In addition, it contains a 14 kb 
extrachromosomal plasmid and a 50 kb mitochondrial genome (85, 185). In N. gruberi, 
mitochondrial DNA is estimated to be 14% of the total cell DNA (186), while A. castellanii 
contains 20 – 30% of the total cell DNA (181). The mitochondrial genome and a 60-kb segment 
of nuclear genome from N. fowleri is suggests the presence of potential pathogenicity factors, 
including ten novel N. fowleri-specific genes and a homolog of cathepsin B protease (185-187).  
7.2. Classification 
The International Society of Protistologists has classified Eukaryotes into six “Super 
Groups” namely, Amoebozoa,  Opisthokonta,  Rhizaria, Archaeplastida, Chromalveolata, and  
Excavata. Among free-living pathogens, genus Acanthamoeba and Balamuthia are included 
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under Super Group Amoebozoa: Acanthamoebidae; while genus Sappinia under Super Group 
Amoebozoa: Flabellinea: Thecamoebidae; and genus Naegleria under Super Group Excavata: 
Heterolobosia: Vahlkampfiidae (188). N. fowleri fit in the genus Naegleria, family 
Vahlkampfiidae in the class Heterolobosea. Like all other members of this class, it is a free-
living protist that feeds typically on bacteria and contains both pathogenic and non-pathogenic 
species.  
The rRNA genes have been used for classification. The rRNAgenes are transcribed 
together in the following order: small subunit (18S) rDNA, an internal transcribed spacer (ITS1), 
5.8SrDNA, a second ITS (ITS2), and the large subunit (28S) rDNA (195). ITS sequence is 
rapidly evolving and has been used to classify over 40 species of Naegleria (185). N. fowleri 
remains the only species responsible for PAM. The rDNA of N. gruberi (28S, 18S, 5.8S) is 
encoded on an extrachromosomal circular nucleolar plasmid carrying all three rDNA genes. The 
3,000 to 5,000 copies per cell of this 14-kilobase-pair circular plasmid convey all the 18S, 28S, 
and 5.8S rRNA genes. The presence of the ribosomal DNA of an organism completely on a 
circular extrachromosomal element is unusual (189). Comparison of the small-subunit ribosomal 
RNA gene with the rRNA sequences of other eukaryotes resulted in a phylogenetic tree that 
supports the proposed polyphyletic origin of N. fowleri and suggests a flagellate ancestry for 
Naegleria (190-192). 
8. Cellular differentiation in N. fowleri 
 The ability of N. fowleri to transform into three distinct stages is remarakable. This 
property is stably inherited, and phenotypic changes occur without change in genotype (152). 
Amoebae encyst during late stationary phase (165). Encystation is categorised by an increase in 
cytoplasmic density (153, 154). The mitochondria are found closely concomitant with the 
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endoplasmic reticulum. Numerous vacuoles of low electron density arise in the vicinity of the 
nucleus and are scattered through the cytoplasm. The mature cyst wall is double wall, comprising 
of an inner thick component (200 – 450 nm) and an outer thin component (25 nm). The two 
layers are separated by a space filled with a network but joined at region of the cyst pore. The 
pores (about 600 nm) are sealed by a plug of electron-transparent material. During excystation, 
the amoeba cytoplasm becomes highly alveolar. The plug closing the pore in the wall, dissolves 
and the amoeba exits the cyst (153, 154). In the initial stages of encystation, the cisternae of the 
endoplasmic reticulum becomes densely filled with a fibrillar material (193). Vesicles with a 
similar content that appears to be derived from the cisternae is also observed in close contact 
with the plasma membrane. As encystation progresses, the fibrillar material becomes localized 
on the surface of the amoeba. Completely formed cysts possess 2 – 3 ostioles, each sealed by an 
operculum. When excystation is induced, small dense granules, which are in close contact with 
fibrillar material are observed in the cyst cytoplasm and in the peritrophic space. During 
excystation, the more compact component of the operculum moves to enable the pseudopod of 
the emerging trophozoite to penetrate the ostiole (194). Excystation of N. fowleri occurrs by 
rupture of the cyst wall (195). The optimum temperature for excystation is about 30°C and 
optimum pCO2 in air is 5%. Inhibitors of carbonic anhydrase reduces excystation (196). The 
excystation is inhibited by actinomycin D, and DNA transcription is apparently obligatory. Once 
excystation initiates, it proceeds to completion in atmospheric CO2. The cellular differentiation is 
affected by the presence of steroids (197). At high concentrations, progesterone and 
deoxycorticosterone prevent amoebae to change to the flagellate form. Flagella are made by 
filamentous extension from endoplasmic protrusion (198). A chromatin body of cytoplasmic 
origin is always located at the base of the protrusion or of the flagella, and is thought to be the 
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parabasal body. Reversion from the flagellate to the amoeba stage is achieved by absorption of 
the flagella, shedding of one or more flagella and absorption of the rest, or by casting-off a small 
part of the body to which the flagella are attached (198). Flagellates have an intersected flagellar 
apparatus, comprising of nucleus, rhizoplast and accessory filaments, basal bodies, and flagella 
(199). A basal body appears and assumes a position at the cell surface with its filaments 
perpendicular to the cell membrane. Axoneme filaments extend from the basal body filaments 
into a progressive evagination of the cell membrane which becomes the flagellum sheath. 
Continued elongation of the axoneme filaments leads to differentiation of a fully formed 
flagellum within 10 min after the appearance of basal bodies (199). Amoebae that are at the 
stationary phase of growth enflagellate more willingly than actively growing amoebae. Inhibitors 
of oxidative phosphorylation, protein synthesis, RNA synthesis, and DNA synthesis delay or 
block transformation, suggesting that RNA and protein synthesis are required (200). Flagellation 
is accompanied with a decrease in DNA synthesis. Flagellation formation begins 60 min after 
incubation in transformation medium. The nuclear DNA synthesis decreases, while 
mitochondrial DNA synthesis continues. The reduction in the nuclear DNA synthesis in 
differentiating cells is not due to inhibition of initiation of DNA replication, but rather to the 
termination of the DNA replicating process (181, 201).  
9. Growth and life cycle 
Naegleria feed on yeast, algae and both Gram-negative and Gram-positive bacteria (202). 
Food selectivity is observed with findings that filamentous cyanobacteria (e.g., Anabaena, 
Cylindrospermum, Gloeotrichia, and Phormidium) are consumed, while tight threads 
(Oscilltoria) and aggregates (Aphanizomenon) are not ingested (203). Unicellular 
Chroococcaceae (e.g., Synechococcus, Aphanocapsa, and Microcystis) are excreted after 
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ingestion, indicating that food selection takes place inside food vacuoles. Ingestion depends on 
the satiation status of the amoebae, as starved amoebae feed at higher rates compared with 
satiated amoebae (203).  
N. fowleri can be grown simply on the surface of non-nutrient agar overlaid with living or 
dead Enterobacter aerogenes or E. coli or other Gram-negative bacilli (202). Live bacteria 
support optimal growth compared with heat-killed bacteria. Under these conditions, the ameobae 
feed upon the bacteria, and as growth enters stationary phase and the food supply is used up, N. 
fowleri begin to encyst. Cysts, if kept from drying out, will remain viable for months, possibly 
years.  
The recommended growth medium is Nelson’s medium (0.4 mg of MgSO4, 0.4 mg 
CaCl2, 14.2 mg Na2HPO4, 13.6 mg KH2PO4, 12 mg NaCl, in 100 mL of distilled water and then 
addition of 0.17 g Liver infusion, 0.17 g glucose. This should be autoclaved for 25 min at 121°C, 
followed by the addition of sterile heat inactivated foetal calf serum (final concentration of 10% 
serum) just prior to use (3, 204, 205). N. fowleri reproduces during amoeboid form by binary 
fission and also gives rise to the cyst and flagellate stages. The approximate intervals of G1, S, 
G2, and M phases are 6% M phase (28 min), 38% G1 phase (180 min), 38% S phase (183 min), 
19% G2 phase (90 min), with a total cell cycle time of 8 h. However, shorter estimates of S 
phase are obtained for monoxenic cultures (201). Throughout the stages of mitosis, the nucleolus 
is present. Throughout metaphase, numerous deeply stained DNA condensations following an 
elongated pattern are witnessed, conforming almost surely to tightly grouped chromosomes. The 
nucleus divides by cryptomitosis, a process in which the nuclear membrane does not disappear 
during mitosis, as demonstrated by ultrastructural observations. Centrioles are not found, and a 
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spindle of microtubules is witnessed running the length of the nucleus from pole to pole though, 
they do not come to a focal point (206). 
9.1. Respiration in N. fowleri 
N. fowleri contains many mitochondria and lives in aerobic aqueous environments and 
infects an oxygen-rich brain. Under agitated culture conditions, amoebae consume 30 ng of O 
per min per mg of cell protein during log growth. The lower oxygen consumption explains the 
presence of N. fowleri in warm waters where dissolved oxygen concentrations are substantially 
reduced. During stationary phase, the respiratory rate declines by 3-fold. Mitochondria rapidly 
oxidized glutamate, NADH, pyruvate, succinate, and other Krebs cycle intermediates but slowly 
oxidized lactate and glycerophosphate. The rates of substrate oxidation are ADP dependent and 
phosphorylative efficiencies (ADP:O ratios) are about 1.4 for NAD-linked substrates and 1.0 for 
succinate. The respiratory control ratios are 1.5 to 3 for 11 substrates and dependent on the 
addition of Pi, Mg2+ , and serum albumin to the reaction mixture. Cyanide, azide, malonate, and 
amytal inhibit oxidative phosphorylation of mitochondria, while rotenone inhibit both glutamate 
and succinate oxidation (207). The genome of N. gruberi showed its versatility, and although 
aerobic, its genome predicts anaerobic respiration (204, 208, 210). N. gruberi has a functional 
[FeFe]-hydrogenase, as determined by measuring hydrogen production (210). Hydrogenase 
enzyme is accredited to anaerobic organisms. Hydrogenase is localized in the cytosol, while no 
hydrogenase activity is linked with mitochondria.  
9.2. Storage  
Trophozoites can be stored in axenic culture medium and dimethylsulphoxide (DMSO) 
added to a final concentration of 5%. Cultures are placed directly at -20°C for 60 min, followed 
by a further 60 min at -70°C and then kept in liquid nitrogen. On rapid thawing at 37°C, revival 
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rates are about 8% for N. fowleri (211). Later studies showed tested a variety of conditions of 
cryopreservation (212). The average best conditions for freezing was 1 x 106 exponentially 
growing amoebae per mL of freezing medium,  consisting of 12% DMSO, 20% heat-inactivated 
bovine calf serum, 4% glucose; 30 min equilibration at 23°C (room temperature), followed by 60 
min at -20°C, with storage at -70°C (212). Under these conditions, N. fowleri viability after 1 
month of freezing was 64%. After 12 months of freezing, viability was 47% and after 5 years, 
viability was 38%. The virulence did not decrease during 30 months of freezing (213). At 10 
years of cryostorage, viability was 21% for N. fowleri (213, 214).  
10. Ecology 
N. fowleri is a free-living amoeba that is present in diverse environments including soil, 
water, and air. It has been discovered on all continents, except Antarctica (215, 216). 
Nonetheless, other species of Naegleria have been sequestered from the Antarctica. N. fowleri 
has been isolated from the air during the harmattan in Zaria, Nigeria that proved pathogenic to 
mice (217). N. fowleri is widespread in freshwater lakes (218). Populations in three of five lakes 
sampled routinely reached levels of one amoeba per 25 mL of water tested, during the hot 
summer months (218). When tested for seasonal distribution, population densities of free-living 
amoebae peaked in late summer (219). The occurrence of N. fowleri is often associated with 
elevated temperatures and/or industrial wastewater. N. fowleri showed 100% survival at pH 
ranging from 2.1 to 8.15 (220, 221). Artificial heating of water by power plant discharges 
facilitates proliferation (222), however N. fowleri was not detected outside the reach of the 
thermal pollution (223), suggesting that warm discharge water should not be used for sports and 
recreational purposes. Kasprzak et al., (224) tested two complexes of lakes and canals supplying 
water for two electric power plants, their steam condensors and an adjoining river for the 
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presence of N. fowleri. Sixty-four strains of N. fowleri were isolated, from the steam condensor 
of the power station A and in waters polluted with warm water of this plant. N. fowleri strains 
occurred also in an adjoining river connected with the water system of the power plant. The 
results show the possible role of the steam condensor A as an incubator and regular source of 
pollution with pathogenic amoebae for its own system of cooling waters and even the adjoining 
river (224). During periods of thermal additions to cooling towers, amoebae concentrations 
amplified by as much as 2 orders of magnitude (225). A canal that was draining cooling water 
from a factory showed presence of N. fowleri (226). Amoebae have also been isolated from 
sewage samples (227). Based on these findings, it is widely acknowledged that polluted 
environments are the key sources of potentially pathogenic species of free-living amoebae. This 
was explained by flagellate-empty habitat hypothesis, i.e., human intervention and/or natural 
events eliminate usual competitors and the capability to transform to a motile flagellate confers 
an advantage to N. fowleri in recolonizing (228). 
Swimming pool waters of Mexico city showd the prevalence at 16.77% of pools tested. 
Naegleria were recovered in their cyst forms. Indoor swimming pools require higher free-
chloride residue (229). A high level of chlorine (5.31 mg per mL or more) would counter 
additional factors such as soil contamination. For example, Kadlec et al., (230) located a 
reservoir of N. fowleri in the cracked wall of a swimming pool where repeated outbreaks of PAM 
were observed. N. fowleri is frequently found in or near geothermal baths (231). By installing a 
pipeline between the geothermal sources and the baths and by preventing flooding water from 
entering the baths after rainfall, it is  possible to reduce the concentration of amoebae in 
geothermal baths (232). N. fowleri has been isolated from hot springs in Yellowstone and Grand 
Teton National Parks (233). 
32 
 
The widespread presence of amoebae in the environment is further demonstrated by 
prevalence of anti-Naegleria spp. antibodies in various wild mammals (234). In other studies, a 
total of 508 reptiles were captured at Canary Islands (Spain) and examined for free-living 
amoebas. Two hundred seventy-three clones of amoebas were isolated by culture of gut contents, 
157 of them belonging to the genus Acanthamoeba and 12 to the genus Naegleria (235). 
Naegleria spp. have also been isolated from organs of freshwater fish (236, 237).  
In addition, Naegleria spp. have also been isolated from the moist areas in 
physiotherapeutic departments of hospitals (238), dust samples in hospitals in Brazil (239), 
dental treatment units tested (240, 241). N. fowleri have been isolated from swabs taken from 
nose, mouth, and pharynx, suggesting that healthy patients are carriers of pathogenic protists 
(242, 243). Antibodies to N. fowleri have been detected in surveys of normal human sera and 
saliva with titres ranging from 1:5 to 1:20 and antibodies belonged to IgA, IgG, and IgM (3, 122, 
124, 125, 244). Recently, Reveiller et al., (124) developed ELISA for rapid identification of N. 
fowleri in environmental water samples. Flow cytometry has also proven efficient for detection 
of N. fowleri from river and surface water samples (245-247). PCR-based assays have been 
developed that can detect up to 10 trophozoites or cysts from environmental samples (248, 249). 
A multiplex PCR has also been developed to simultaneously detect N. fowleri and other 
Naegleria species in the environment (250, 251). Recently, Ahmad et al., (252) developed a 
nested one-step PCR test, in combination with a direct DNA extraction from water or sediment 
material, for the quick and consistent detection of N. fowleri from the environment. Mull et al., 
(253) used an immunomagnetic separation (IMS) procedure and real-time PCR TaqMan assay to 
recover and quantify N. fowleri in water and sediment samples. Kao et al., (254) used PCR of 
5.8S rRNA gene and ITS region to successfully identify Naegleria isolates and quantify the 
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Naegleria spp. by TaqMan real-time quantitative PCR in reservoir water samples. Overall, these 
rapid, specific and sensitive assays are useful to facilitate studies of the physical, chemical, and 
biological factors associated with the presence and dynamics of N. fowleri in the environmental 
systems. Following detection of amoebae in the enviromental sample, chlorine was shown to be 
effective disinfectant against N. fowleri (255) in drinking water and swimming pools. 
Hypochlorite, at a concentration of 0.5 mg per L, killed 100% Naegleria after 1 h exposure 
(25°C, pH 7.3 – 7.4) (256). Later studies tested the efficacy of monochloramine against 
planktonic forms (trophozoites and cysts) and also biofilm-associated cells of N. fowleri as they 
are often associated with biofilms. The effective range was shown to vary from 4 to 17 mg Cl2 
per L at 25°C and pH 8.2 on both planktonic and biofilm associated cells (257). More recently, 
Miller et al., (258) showed that N. fowleri associated with drinking water distribution biofilm 
exhibit increased resistance to chlorine. The laboratory starin survived up to 0.6 mg per L 
chlorine. In comparison, parasite associated with an attached drinking water distribution biofilm 
survived more than 30 times (20 mg per L) the recommended concentration of chlorine for 
drinking water suggesting that N. fowleri can resist field drinking water distribution biofilm 
despite chlorination (258). 
11. Host for other microbes 
In addition to produce fatal infections, N. fowleri are recognized as environmental hosts. 
For the first time, Schuster (259) described intranuclear virus-like bodies in cultures of 
Naegleria. The particles were approximately 100 nm in diameter, and largely restricted to the 
nucleus. Passage of particles from the nucleoplasm into the cytoplasm was suggested by their 
association with tubular projections from the nuclear membrane, and particles were seen in the 
cytoplasm of the amoebae. It was suggested that the virus-like bodies resemble reovirus (260-
34 
 
262). The subcellular infectious material in Naegleria was capable of infecting chick embryo 
cells and causing them to undergo cytopathic changes with the release of infectious material. The 
cytopathogenic agent was filterable and passageable and present in N. gruberi or N. fowleri (263, 
264).  
Phillips (64) reported the presence of intracellular diphtheroids. The organisms could be 
eliminated by antibiotic treatment but amoebae was shown to grow better in its presence 
suggesting a symbiotic relationship. Studies of the interaction of Legionella pneumophila with 
free-living amoebae showed that Naegleria could use L. pneumophila as a sole food source 
(265). Some N. fowleri cultures support the growth of L. pneumophila. Amoebae association 
with L. pneumophila show no increase in the pathogenic potential on intranasal inoculation of 
mice. Similarly, L. pneumophila propagate in infected N. fowleri cultures show no increase in 
virulence. Photomicrographs show intracellular vacuoles containing L. pneumophila in the 
process of binary fission (266, 267). Notably, non-Legionella bacteria (E. coli, Aeromonas 
hydrophila, Flavobacterium breve, and Pseudomonas aeruginosa) did not contest with L. 
pneumophila for uptake, proposing that the amoeba hosts took in L. pneumophila through a 
specific and presumably extremely efficient uptake mechanism. These results highlight 
Naegleria as a useful host for the replication and distribution of L. pneumophila (268). Bacterial 
attachment and uptake occurs through a receptor-mediated endocytosis, which requires de novo 
synthesis of host proteins. L. pneumophila show a high affinity to GalNAcbeta1-4Gal domain of 
the N-acetyl-D-galactosamine receptor of Naegleria (269). The knowledge of endosymbiont in 
N. fowleri is limited, however several lines of evidence suggest that endosymbionts play a key 
role in the biology of N. gruberi (270, 271). Using amoeba co-culture, Casson et al., (272) 
isolated a Naegleria endosymbiont. Phenotypic, genetic, and phylogenetic analyses supported its 
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affiliation as Protochlamydia naegleriophila sp. nov. that may have a role in pneumonia (Fig. 6) 
(272). V. cholerae survive ingestion within amoebae and subsequent encystation (273). The high 
abundance in lakes, ponds and water circulation networks of these organisms indicate their 
potential symbiotic relationship, perhaps contributing to the survival and propagation of these 
pathogens to humans and other animals.  
12. Conclusions and Future Studies 
12.1. Rapid and non-invasive diagnosis 
 Given the rarity of the disease, lack of awareness, and similarities with bacterial 
meningitis, PAM is rarely thought of as the indicative cause. A high suspicion for PAM is 
considered following negative cultures for bacteria in the CSF and a history of swimming/nasal 
irrigation. Given the high intracranial pressure in PAM patients, CSF collection may complicate 
the clinical scenario leading to brain herniation (6, 274). Naturally, the emphasis is to lower the 
intracranial pressure. Amoebae enter the brain through the nasal passage, and then travel along 
the olfactory neuroepithelial route and infect inferior surface of the frontal lobe. Amoebae 
propogate in this area followed by dissemination in the CNS. It makes sense to collect nasal 
secretions from the primary site of infection for the identification of N. fowleri (275). In support, 
Singh et al., (276) observed amoebae in the CSF and nasal secretions of a PAM-infected patient 
and confirmed N. fowleri through culture (276), demonstrating the usefulness of nasal secretions 
as a diagnostic tool. The wet preparation can be examined under the microscope or using PCR-
based assays to detect N. fowleri for rapid, non-invasive identification of N. fowleri and this 
should be investigated in future research.  
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11.2. Antiamoebic anesthetic agents  
As recent studies showed anti-amoebic (amoebistatic and partial amoebicidal) effects of 
anesthetic agents, haloperidol and loperamide (277, 278), it is suggested that aforementioned 
agents should be added to complement therapeutic interventions by inhalation to exert anti-N. 
fowleri effects at the primary site of infection. The use a ‘transcribrial route’ (275) device for 
vaporized delivery of chemotherapeutic agents should be investigated in the future studies. Such 
a delivery method overcome challenges of the current intraventricular, intrathecal, intravenous 
methods that have added complications of side effects and/or difficulty in achieving MIC at the 
site of the infection, following intravenous injections, and/or drainage into the blood following 
CSF injections. Moreover the proposed route will avoid challenges of drug penetration through 
the highly selective blood-brain barrier and could be a useful method to apply drugs directly on 
the target site, without affecting other tissues due to systemic dissemination and diluting their 
effects needlessly. Further research is needed to determine the effectiveness of the proposed 
methods for effective management to help improve morbidity and mortality of N. fowleri 
infection.    
11.3. Drug repurposing  
Testing of drugs that are clinically-approved against various diseases with known 
mechanisms of action and targets/biochemical pathways offers useful research avenues, as the 
pharmacokinetics profiles, safety margins etc. have been already established. Recently, Baig et 
al., (277, 278) have shown amoebicidal effects of some of the FDA-approved drugs such as 
digoxin and procyclidine. This approach can offer promising drug-leads for clinical practice. 
Based on the few drugs tested with promising anti-amoebic effects, there is a need for high 
throughput screening using available chemical libraries/FDA-approved to identify potential anti-
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N. fowleri compounds. Once a number of potential compounds are identified in vitro, with 
known pharmacokinetics, and pharmacodynamics profiles, the findings can lead to in vivo testing 
at a faster pace. The drug discovery of effective anti-N. fowleri drugs over the last few decades 
has been disappointing, largely due to neglect by the funding agencies. The fact that PAM is a 
rare disease in developed countries and affects communities mostly in developing countries, 
where millions of people are dying due to other diseases, makes it logical to undertake drug 
repurposing approach in our search for effective anti-N. fowleri drugs.  
11.4. Biomarkers 
Absence of distinct biomarker(s) of PAM in the mucosal secretions, blood, CSF makes it 
difficult to study the impact of interventions against it. Biomarkers for PAM have been 
challenging to find, partly because of our inadequate understanding of its pathogenesis and 
pathophysiology. Thus there is a need to identify novel biomarkers for PAM. Using analytical 
tools such as mass-spectrometry, NMR etc., there is also a need to study and compare 
biochemical profiles of pathogenenic and non-pathogenic Naegleria as well as patients from 
different populations, gender, ethinicity to identify potential predisposing factors. The paucity of 
PAM studies during the last few decades is partly to blame for the lack of understanding of the 
pathogenesis and pathophysiology of PAM, and the subsequent lack of its good biomarkers. 
Major technological advances in studying pathophysiologic mechanisms in general have not 
been applied to the study of PAM so far. If we are to identify sensitive and specific biomarkers 
of PAM, we must first understand the pathophysiologic mechanisms that underlie this disease. 
The reasons for the lack of aforementioned studies are multifactorial. An important issue is that 
PAM is rare and/or occurs in resource-limited settings, which may not have the infrastructure to 
perform such experimentation or have other research priorities of health-related problems of 
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major significance. There, clearly, is a need to identify and test new promising candidate 
biomarkers of PAM in mucosal secretions, blood, and CSF, and then correlating them with the 
histopathologic features of affected patients, which will provide a mechanistic basis of PAM.  
11.5. Drug targets  
A complete understanding of the biology and pathogenesis of N. fowleri will identify 
molecules that could be of value to develop therapeutic interventions. Ondarza (279) suggested 
that exploration of several pathways can reveal drug targets, including, a) hydrolytic enzymes for 
host tissue invasion, b) glycolytic enzymes, that are differerentially expressed by the parasite, c) 
thiol-based redox metabolism pathways, d) oxidative stress pathway, e) trypanothione pathways, 
and f) encystation and excystation pathways.   
11.6. A model organism with the pathogenic potential  
The biology of N. fowleri is fascinating. With its ability to switch phenotypes to an active 
trophozoite stage to grow vegetatively, or transform into a flagellate stage to travel long distance, 
or switch into a dormant cyst form to endure callous conditions, as well as the fact that it is a 
single-celled eukaryotic protist, it is an excellent organism for the study of biochemistry, cellular 
microbiology, molecular mechanisms of cell differentiation, physiology, cellular interactions 
with other microbes or human cells, phagocytosis, flagellar and amoebal motility, and 
evolutionary studies. A complete understanding of the molecular and cellular biology of N. 
fowleri to encyst, flagellate, excyst, transmit, evade host defences and produce disease will 
identify potential targets for the rational development of therapeutic interventions.  
Future goals are to find means to identify individuals who are at risk and to provide them 
with rationally-designed strategies to protect against the infection. The preventative strategies 
may vary among different communities, from the use of chlorine or filters to decontaminate 
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water, or the use of nose clips or use of clean water for nasal cleansing/irrigation. It is known that 
binding of trophozoite to nasal mucosa is the first step in N. fowleri infection, and induction of 
mucosal immunity is another avenue to counter infection progression. Several virulence factors 
have been described, some of which are potential vaccine targets for the susceptible population. 
The availability of the genome information as well as in vitro and in vivo models will expedite 
the identification of novel drug targets further, through genomics, proteomics and bioinformatics. 
Given the rarity of the disease, chemotherapy will remain the primary choice to develop 
therapeutic interventions. Many of the drugs tested target the functional aspects of N. fowleri, 
however, being a eukaryote N. fowleri share functional homologies to mammalian cells. 
Consequently, many of the available drugs cannot be prescribed at effective concentrations due 
to their unwanted side effects. This is particularly relevant for N. fowleri infection, as drugs are 
given intravenously in most cases, and must get through the brain microvessels to target the 
intracerebral N. fowleri. In this process, drugs target all tissues, and can affect their physiology 
before reaching the target site, at effective concentration. Hence, there is a need to develop a 
targeted therapeutic approach, or identify drugs that can affect parasite viability without affecting 
host cells. Future research is needed to to identify drugs and/or chemotherapeutic approaches of 
potential value, together with improved understanding of drugs, targets, and their underlying 
mechanisms that will facilitate the development of more effective chemotherapies against this 
rare, but fatal infection. There is an urgent need for continued research in developing 
preventative strategies as well as understanding pathogenesis and designing effective anti-N. 
fowleri chemotherapeutic and immuno-therapeutic approaches against PAM and demonstrating 
their efficacy in the clinical practice. Furthermore, educational efforts are needed to increase 
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knowledge of this parasite, disease and associated risk factors, by the medical practitioners, 
public, health officials, and the local government.  
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Figure legends 
Figure 1. Naegleria fowleri (a) trophozoite form, (b) flagellate form, and (c) cyst form (courtesy: 
B. S. Robinson, Australian Water Quality Centre, South Australian Water Corporation). Bar is = 
10 μm. 
Figure 2. Pathological features of primary amoebic meningoencephalitis caused by Naegleria 
fowleri. (a) A cerebrospinal fluid smear stained with Giemsa stain. Note amoebae at arrows (× 
1000). (b) A section through the cerebellum showing extensive inflammation. (c) An area of the 
cerebellum showing extensive destruction of the brain architecture with large numbers of 
amoebae in the perivascular area (× 1000). (d) A section, similar to the one shown in (c), but 
reacted with anti-N. fowleri serum. Note the brightly staining N. fowleri trophozoites (kindly 
provided by G. S. Visvesvara from FEMS Immunol Med Microbiol. 2007, 50, 1-26).  
Figure 3. Thousands of people can be seen swimming in the canal that passes through the city of 
Lahore, Pakistan, without nearby facilities for defecation and urination.  
Figure 4. Nasal cleansing/irrigation using neti pots can provide relief to patients with sinusitis by 
flushing out excess mucus and debris from the nose (a and b). Ablution involves nasal cleansing 
(c). The use of contaminated water together with forceful pushing up the nostrils even though it 
is not required as part of the ablution practice or swimming in contaminated water (d) or 
unchlorinated pools with amoebae can lead to parasite entry into the brain.  
Figure 5. Factors associated with the pathogenesis of Naegleria fowleri infection.  
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Figure 6. Naegleria lovaniensis with Protochlamydia naegleriophila, strain KNic, as 
endoparasites (P). Bar is 1.0 µm (kindly provided by R. Michel and B. Hauröder, Central 
Institute of the Armed Forces Medical Service, Koblenz, Germany).   
 
 
